UK-356618

• 产品号: PZ0152
• CAS号: 230961-08-7
• 分子式: C34H43N3O4
• 分子量: 557.72292
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: UK-356618
• IUPAC标准名: (2R)-N-[(1S)-2,2-dimethyl-1-{[(1R)-1-phenylethyl]carbamoyl}propyl]-N'-hydroxy-2-[3-(3-methyl-4-phenylphenyl)propyl]butanediamide
• IUPAC传统名: (2R)-N-[(1S)-2,2-dimethyl-1-{[(1R)-1-phenylethyl]carbamoyl}propyl]-N'-hydroxy-2-[3-(3-methyl-4-phenylphenyl)propyl]butanediamide
• 别名: (2R)-N1-[(1S)-2,2-Dimethyl-1-({[(1R)-1-phenylethyl]amino}carbonyl)propyl]-2-{3-[(3-methyl-4-phenyl)-phenyl]propyl}-(N4-hydroxy)butanediamide; UK-356,618

产品登记号

• MDL号: MFCD19443865
• CAS号: 230961-08-7

产品性质

• Empirical Formula (Hill Notation): C34H43N3O4
• 纯度: ≥98% (HPLC)
• 外观: white to tan powder
• 比旋光度: [α]/D >+25.0°, c = 0.5 in methanol
• 溶解度: DMSO: ≥25 mg/mL
• GHS警示词: Warning
• GHS危险声明: H302
• 欧盟危险性物质标志: 有害性(Harmful) (Xn)
• 危险公开号: 22
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
UK-356,618 is a potent, selective inhibitor of Matrix metalloproteinase MMP3 (stromelysin-1). MMP-3 IC50 = 5.9 nM, selectivity is 140-fold vs MMP-1, -2, -9, and -14.

详细说明 (简体中文)

Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
UK-356,618 is a potent, selective inhibitor of Matrix metalloproteinase MMP3 (stromelysin-1). MMP-3 IC50 = 5.9 nM, selectivity is 140-fold vs MMP-1, -2, -9, and -14.